Financial Advocates Investment Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,112
| Closed | -$417K | – | 643 |
|
|
2025
Q1 | $417K | Sell |
6,112
-6
| -0.1% | -$410 | 0.03% | 465 |
|
|
2024
Q4 | $476K | Buy |
+6,118
| New | +$476K | 0.03% | 461 |
|
|
2023
Q4 | – | Sell |
-2,636
| Closed | -$246K | – | 731 |
|
|
2023
Q3 | $246K | Sell |
2,636
-157
| -6% | -$14.6K | 0.02% | 584 |
|
|
2023
Q2 | $359K | Buy |
2,793
+168
| +6% | +$21.6K | 0.03% | 472 |
|
|
2023
Q1 | $305K | Sell |
2,625
-5,981
| -69% | -$695K | 0.02% | 545 |
|
|
2022
Q4 | $975K | Buy |
8,606
+3,717
| +76% | +$421K | 0.07% | 291 |
|
|
2022
Q3 | $268K | Buy |
4,889
+1,376
| +39% | +$75.4K | 0.02% | 579 |
|
|
2022
Q2 | $262K | Buy |
+3,513
| New | +$262K | 0.02% | 544 |
|
|
2022
Q1 | – | Sell |
-10,084
| Closed | -$1.3M | – | 748 |
|
|
2021
Q4 | $1.3M | Buy |
+10,084
| New | +$1.3M | 0.08% | 275 |
|
|
2020
Q4 | – | Sell |
-3,088
| Closed | -$318K | – | 716 |
|
|
2020
Q3 | $318K | Buy |
+3,088
| New | +$318K | 0.03% | 458 |
|